Biotech

Latest Articles

Cassava pays $40M over presumably deceiving Alzheimer's improve

.Cassava Sciences has agreed to spend $40 million to fix an investigation into cases it created dece...

Merck bags options on Evaxion's AI-designed injection applicants

.Merck &amp Co. has actually picked up alternatives on 2 Evaxion Biotech injection applicants, payin...

Enanta's RSV antiviral crushes popular bunch in obstacle research study

.Enanta Pharmaceuticals has actually connected its own respiratory syncytial virus (RSV) antiviral t...

Biogen cans SAGE-324 collaboration after crucial agitation neglect

.Biogen has provided the last rites to its collaboration with Sage Rehabs on SAGE-324, scrapping the...

AbbVie Parkinson's drug coming from $8.7 B Cerevel purchase scores

.On the exact same day that some Parkinson's disease medications are actually being actually brought...

Arch shuts $3B-plus fund to cultivate biopharma startups

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arc Venture Partne...

Orion to use Aitia's 'digital doubles' to discover brand-new cancer drugs

.Finnish biotech Orion has actually snooped potential in Aitia's "digital double" technology to cult...

Windtree's shock med raises blood pressure in most up-to-date period 2 succeed

.While Windtree Therapeutics has actually had a hard time to expand the financial origins required t...

2 cancer biotechs merge, making global impact

.OncoC4 is taking AcroImmune-- as well as its own internal medical manufacturing abilities-- under i...

Amgen files 1st phase 3 gain for $400M dermatitis drug

.Amgen has actually discussed (PDF) the first period 3 information on its own $400 million dermatiti...

Biogen, UCB report period 3 lupus win after falling short earlier test

.Biogen and also UCB's bank on improving into phase 3 astride an unsuccessful research study seeks t...

Aptadir wishes new RNA preventions can turn around difficult cancers

.Italian biotech Aptadir Therapeutics has introduced along with the pledge that its pipe of preclini...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Wave Life Sciences has met its own target in a Duchenne muscle dystrophy (DMD) study, installing it...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, occupyi...

Achilles droplets cell treatment plan, supports for unemployments after overlooking 'office stability' goals

.Achilles Therapeutics has actually shreded its technique. The British biotech is actually stopping ...

Aligos proclaims phase 2 MASH succeed, slashing liver excess fat approximately 46%

.Aligos Therapeutics is actually advertising a midstage win in metabolic-dysfunction linked steatohe...

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job establishing brand new antifungals has actually obtained a notable incr...

Capricor sells Europe legal rights to late-stage DMD treatment for $35M

.Possessing actually scooped up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne mus...

FDA scraps adcomm for Applied's unusual disease medicine

.After dismissing the decision meeting for Applied Therapeutics' metabolic ailment drug govorestat, ...

Novo inks $600M NanoVation deal to research hereditary drugs ex-liver

.Novo Nordisk is proceeding its press right into hereditary medications, agreeing to pay NanoVation ...